Biogen Put Volume Heavy and Directionally Bearish
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Are Biogen Inc.'s (NASDAQ:BIIB) Mixed Financials Driving The Negative Sentiment?
Anavex Gains After Seeking EU Marketing Nod for Alzheimer's Drug
Jefferies Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $250
Jefferies Remains a Buy on Biogen (BIIB)
S&P 500, Dow Hit Records Right After Open | Live Stock
Are Wall Street Analysts Predicting Biogen Stock Will Climb or Sink?
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Market Climbs, Bitcoin Close to $100k | Live Stock
Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock
Biogen Price Target Lowered to $207 From $251 at Mizuho
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Optimism Over Global Healthcare Sector Rises: Jefferies
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Mizuho Maintains Outperform on Biogen, Lowers Price Target to $207
Biogen Analyst Ratings
Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating, Announces Target Price $207
European Commission Approves Samsung Bioepis, Biogen's Biosimilar Opuviz